Bristol Blue Glass, a UK glassmaker, to close in May due to rising energy costs and taxes, questioning viability of UK manufacturing.
NEWSAIPirelli is suing Grizzly Research for defamation after the short-seller published a report alleging close ties to Russia and potential security risks for the West. Grizzly claimed Pirelli's Russian operations are more significant than disclosed and may supply the Russian military.
NEWSAICrowdStrike exceeded Q1 earnings and revenue expectations but saw its stock fall 10% post-report. The cybersecurity firm announced a 4-for-1 stock split and highlighted growth driven by AI adoption and new security solutions.
NEWSAIKalshi, a prediction market platform, is partnering with a New York City bar, The Jeffery, to demonstrate its hedging strategy for small businesses. The bar placed a $5,000 trade on the Knicks winning their game against the Spurs, aiming to cover customer tabs if they win, or profit from increased business if they lose.
NEWSAIMany young Londoners are struggling with the Lifetime ISA (LISA) due to its £450,000 property price cap, which is out of sync with the capital's housing market. This leads to significant financial penalties for those who withdraw funds, with unauthorised withdrawals outnumbering house purchases via LISA in 2024-25.
NEWSAIElon Musk, the world's richest person, is on track to potentially become a trillionaire. His ventures in Tesla, SpaceX, and AI, alongside his controversial political involvement, shape his immense wealth and influence.
NEWSAICanada has become the first G7 nation to approve generic semaglutide injections, making GLP-1 drugs more accessible and affordable. This move by Novo Nordisk follows similar approvals in India and may pressure US prices, though generics are not expected there until 2032.
